WELCOME TO Q-MED
|
Q-Med is a medical device company that primarily develops, manufactures, markets and sells medical implants. Most of the products are based on the company's patented technology, NASHA™, for the production of stabilized non-animal hyaluronic acid.
The company today has approximately 650 co-workers in 20 countries, with approximately 400 at the company's head office and production facility in Uppsala.
Q-Med had sales of 1,272 MSEK during 2008. Q-Med AB is listed in the Mid Cap segment of the NASDAQ OMX Nordic.
|
|
|
|
|
|
Success for Q-Med at IMCAS
|
January 13, 2010
At the 12th IMCAS Congress (International Master Course on Aging Skin) in Paris from January 8 to January 11, Q-Med presented a number of new devices, amongst other things a new version of the prize-winning Restylane® Injector and a new ultra sharp needle – the “Thin Wall Needle” – that facilitates injection and reduces the discomfort for the patient, along with new treatment concepts for Restylane®. Great interest was shown in the first two years with MacrolaneTM on the market and MacrolaneTM was described as an established, safe and purpose-designed product that is attracting new customer groups.
|
|
|
|
|
|
|
February 2, 2010
Q-Med's Year-End report will be released on February 12, 2010, at approx. 8 a.m. CET.
There will be a telephone conference on Friday, February 12 at 10.30 a.m.
|
 Invitation to conference call, read more
|
|
|
|
Restylane® Lidocaine and Perlane® Lidocaine approved in USA
|
3, February 2010
Restylane® Lidocaine and Perlane® Lidocaine have been approved by the FDA (U.S. Food and Drug Administration). Medicis, Q-Med´s partner in the U.S., anticipates shipping the products in the U.S. within the next 30 days. Lidocaine is a local anaesthetic. In clinical studies supporting approval, the addition of lidocaine to Restylane and Restylane Perlane substantially reduced pain experienced by patients.
Read more
|
|
|
|
|
|
|
|
QMED 08/02/2010 18:00:01
-1.29% -0.75 sek, Vol: 126,686
Last: 57.50 sek
High: 59.50 sek Low: 56.00 sek
The Q-Med share
|
|
|
|
|
|
|